RT Journal Article
SR Electronic
T1 Convergent functional effects of antidepressants in major depressive disorder: a neuroimaging meta-analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.24.23298991
DO 10.1101/2023.11.24.23298991
A1 Saberi, Amin
A1 Ebneabbasi, Amir
A1 Rahimi, Sama
A1 Sarebannejad, Sara
A1 Sen, Zumrut Duygu
A1 Graf, Heiko
A1 Walter, Martin
A1 Sorg, Christian
A1 Camilleri, Julia A.
A1 Laird, Angela R.
A1 Fox, Peter T.
A1 Valk, Sofie L.
A1 Eickhoff, Simon B.
A1 Tahmasian, Masoud
YR 2023
UL http://medrxiv.org/content/early/2023/11/27/2023.11.24.23298991.abstract
AB Background Neuroimaging studies have provided valuable insights into the macroscale impacts of antidepressants on brain functions in patients with major depressive disorder. However, the findings of individual studies are inconsistent. Here, we aimed to provide a quantitative synthesis of the literature to identify convergence of the reported findings at both regional and network levels and to examine their associations with neurotransmitter systems.Methods Through a comprehensive search in PubMed and Scopus databases, we reviewed 5,258 abstracts and identified 37 eligible functional neuroimaging studies on antidepressant effects in major depressive disorder. Activation likelihood estimation was used to investigate regional convergence of the reported foci of consistent antidepressant effects, followed by functional decoding and connectivity mapping of the convergent clusters. Additionally, utilizing group-averaged data from the Human Connectome Project, we assessed convergent resting-state functional connectivity patterns of the reported foci. Next, we compared the convergent circuit with the circuits targeted by transcranial magnetic stimulation (TMS) therapy. Last, we studied the association of regional and network-level convergence maps with the selected neurotransmitter receptors/transporters maps.Results We found regional convergence of the reported treatment-associated increases of functional measures in the left dorsolateral prefrontal cortex, which was associated with working memory and attention behavioral domains. No regional convergence was found across foci of alterations in functional imaging associated with antidepressants. Moreover, we found network-level convergence of functional alterations in a circuit that was prominent in the frontoparietal and salience networks. This circuit was co-aligned with a circuit targeted by anti-subgenual TMS therapy. We observed no significant correlations between our meta-analytic findings with the maps of neurotransmitter receptors/transporters.Conclusion Our findings highlight the importance of the left dorsolateral prefrontal cortex, as well as frontoparietal network and the salience network in the therapeutic effects of anti-depressants, possibly associated with their role in improving executive functions and emotional processing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAS and SLV were funded by the Max Planck Society (Otto Hahn award) and Helmholtz Association Initiative and Networking Fund under the Helmholtz International Lab grant agreement InterLabs0015, and the Canada First Research Excellence Fund (CFREF Competition 2, 2015 2016) awarded to the Healthy Brains, Healthy Lives initiative at McGill University, through the Helmholtz International BigBrain Analytics and Learning Laboratory (HIBALL). SBE was supported by the Deutsche Forschungsgemeinschaft (DFG, EI 816/211), the National Institute of Mental Health (R01MH074457), and the European Union Horizon 2020 Research and Innovation Programme under Grant Agreement No. 945539 (HBP SGA3).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The results of previous neuroimaging studies on the effects of antidepressants have been used.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe coordinates of the foci reported in the included experiments are available in https://doi.org/10.6084/m9.figshare.24592539. The group-averaged dense resting-state functional connectivity matrix from the Human Connectome Project can be accessed at https://db.humanconnectome.org.